medroxyPROGESTERone 150MG/ML,1ML INJ (Depo-Provera)

medroxyPROGESTERone 150MG/ML,1ML INJ (Depo-Provera)

Non-Formulary Use Criteria: 1. Consultation with BOP Chief psychiatrist and /or Central Office Transgender Clinical Management Team when providing transgender care Formulary Restrictions: MEDICAL DIRECTOR APPROVAL REQUIRED IF USED FOR GENDER CHANGE ALL HORMONAL THERAPY BY INMATES UPON ADMISSION INTO THE BOP TO MAINTAIN SECONDARY SEXUAL CHARACTERISTICS MUST BE APPROVED BY THE MEDICAL DIRECTOR ALL DOSAGE CHANGES (INCREASE OR DECREASE) FOR HORMONAL THERAPY TO MAINTAIN SECONDARY SEXUAL CHARACTERISTICS MUST BE PRE-APPROVED BY THE MEDICAL DIRECTOR UTILIZATION IN SEX-OFFENDOR TREATMENT REQUIRES WRITTEN MEDICAL DIRECTOR APPROVAL REFER TO PARAPHILIA TREATMENT GUIDELINE

Dr. M Blatstein

Comments are closed.